Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 6, 2011, Pages 1789-1796

  Burt, Morton G ^a,b   Roberts, Gregory W ^a,b   Aguilar Loza, Norma R ^a   Frith, Peter ^a,b   Stranks, Stephen N ^a,b  

^a REPATRIATION GENERAL HOSPITAL   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INTERMEDIATE ACTING INSULIN; LONG ACTING INSULIN; ORAL ANTIDIABETIC AGENT; PREDNISOLONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEACHING HOSPITAL;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PATIENT SELECTION; POSTPRANDIAL PERIOD; PREDNISOLONE; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79956315741     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2729     Document Type: Article

References (23)

1. Walsh LJ, Wong CA, Pringle M, Tattersfield AE 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344-346 (Pubitemid 26334822)
2. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA 2006 Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 12:358-362 (Pubitemid 44717593)
3. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, Jones PW 2006 Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61:284-289
4. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P 2008 Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610-1619 (Pubitemid 351440650)
5. Krinsley JS 2003 Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471-1478 (Pubitemid 37475630)
6. Weir CJ, Murray GD, Dyker AG, Lees KR 1997 Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 314:1303-1306 (Pubitemid 27183316)
7. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE 2009 American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32:1119-1131
8. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602 (Pubitemid 38033020)
9. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT 2008 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559 (Pubitemid 351831356)
10. Rebrin K, Steil GM, van Antwerp WP, Mastrototaro JJ 1999 Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 277:E561-E571 (Pubitemid 29458218)
11. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV 2001 Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 24:1858-1862 (Pubitemid 33716491)
12. Oyer DS, Shah A, Bettenhausen S 2006 How to manage steroid diabetes in the patient with cancer. J Support Oncol 4:479-483 (Pubitemid 44698157)
13. Clore JN, Thurby-Hay L 2009 Glucocorticoid-induced hyperglycemia. Endocr Pract 15:469-474
14. Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Kojima M 2004 Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Pharmacotherapy 24:508-514 (Pubitemid 38420539)
15. Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A 2007 Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron 105:c54-c57 (Pubitemid 46143906)
16. Magee MH, Blum RA, Lates CD, Jusko WJ 2002 Pharmacokinetic/ pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation. Br J Clin Pharmacol 53:474-484 (Pubitemid 34526499)
17. Darmon P, Dadoun F, Boullu-Ciocca S, Grino M, Alessi MC, Dutour A 2006 Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity. Am J Physiol 291:E995-E1002
18. Henriksen JE, Alford F, Ward GM, Beck-Nielsen H 1997 Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients. Diabetologia 40:1439-1448 (Pubitemid 28004938)
19. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE 2002 Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982 (Pubitemid 36121050)
20. Dungan KM, Braithwaite SS, Preiser JC 2009 Stress hyperglycaemia. Lancet 373:1798-1807
21. Chakrabarti B, Angus RM, Agarwal S, Lane S, Calverley PM 2009 Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD. Thorax 64:857-862
22. Gurwitz JH, Bohn RL, Glynn RJ, Monane M, Mogun H, Avorn J 1994 Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 154:97-101 (Pubitemid 24018107)
23. Sachedina N, Pickup JC 2003 Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in Type 1 diabetic subjects. Diabet Med 20:1012-1015 (Pubitemid 41701482)